R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

In LSX's Obesity Science and Innovation forum, experts gave the inside scoop on the challenges and opportunities that remain in GLP-1s.

R&D

Inside the ecosystem of compounding pharmacies, 503A and 503B facilities are distinct.

R&D

Nikhil Mutyal, head of search and evaluation for respiratory and immunology at AstraZeneca, discusses partnership and external innovation at LSX.

R&D

Precision medicine is finding success in cancer care, but not much elsewhere. The reasons why are often more economic than scientific.

R&D

Advancements in medical AI now allow pharmaceutical companies to leverage unstructured clinical data at scale.

R&D

Epilepsy affects women differently than men, owing to the complexity of brain health and the historical lack of investment in women’s health.